2f:I[703058,["/_next/static/immutable/chunks/3bhq_5eh1d760.js","/_next/static/immutable/chunks/1855-ogyi8eh4.js","/_next/static/immutable/chunks/2pfsjpn6k6zlg.js","/_next/static/immutable/chunks/26c7v3_3uwnwu.js","/_next/static/immutable/chunks/25a3ozcrvi1ff.js","/_next/static/immutable/chunks/2r4wx50nvjh_4.js","/_next/static/immutable/chunks/23fsw06hsi5b1.js","/_next/static/immutable/chunks/06_yt270h41rg.js","/_next/static/immutable/chunks/3ezsiz-7shkna.js","/_next/static/immutable/chunks/20x2y96ldu5wx.js","/_next/static/immutable/chunks/2lxntcm3pd1_h.js","/_next/static/immutable/chunks/00dgco8irq3jw.js","/_next/static/immutable/chunks/00nwe-kq0rboc.js","/_next/static/immutable/chunks/2051ffx3xzio9.js"],"PaperListPageClient"] 30:T773,Failure to complete cancer treatment is associated with worse oncologic outcomes. This 2-year prospective National Quality Improvement (QI) Collaborative aimed to decrease patient- and program-level rates of missed radiotherapy appointments by 20% at American College of Surgeons (ACS)-accredited cancer programs. One hundred ninety-four accredited cancer programs scheduled 99,057 patients for radiotherapy while voluntarily participating in the ACS Breaking Barriers National QI Collaborative from March 2023 to December 2024. Programs identified patients who missed 3 or more planned radiotherapy treatments, completed community needs assessments, engaged in educational webinars and peer learning discussions, and implemented system-level strategies to improve treatment adherence using an ACS toolkit. Chi-square tests assessed differences in rates of missed radiotherapy treatments, barriers addressed, and interventions implemented. Reductions of 39.8% (from 8.3% to 5.0%) and 31.7% (from 8.2% to 5.6%) were seen in no-show rates at the patient and program levels, respectively. Reductions were demonstrated for all program types, for most census regions, and for breast, gynecologic, and gastrointestinal cancers. The most frequently addressed barriers were transportation (62.3%) and patient illness unrelated to toxicity (37.1%). The most frequently implemented interventions included the development of a workflow and/or protocol related to identified barriers (68.9%) and the creation of internal resources to address these barriers (54.3%). Breaking Barriers is the largest prospective study to decrease rates of missed radiotherapy appointments across multiple program types, census regions, and disease sites. These findings demonstrate the strength of ACS-led National QI Collaborative as an effective large-scale approach to address modifiable barriers to high-quality cancer care delivery.31:T9c7, BACKGROUND: Failure to complete cancer treatment is associated with worse oncologic outcomes. This 2-year prospective National Quality Improvement (QI) Collaborative aimed to decrease patient- and program-level rates of missed radiotherapy appointments by 20% at American College of Surgeons (ACS)–accredited cancer programs. STUDY DESIGN: One hundred ninety-four accredited cancer programs scheduled 99,057 patients for radiotherapy while voluntarily participating in the ACS Breaking Barriers National QI Collaborative from March 2023 to December 2024. Programs identified patients who missed 3 or more planned radiotherapy treatments, completed community needs assessments, engaged in educational webinars and peer learning discussions, and implemented system-level strategies to improve treatment adherence using an ACS toolkit. Chi-square tests assessed differences in rates of missed radiotherapy treatments, barriers addressed, and interventions implemented. RESULTS: Reductions of 39.8% (from 8.3% to 5.0%) and 31.7% (from 8.2% to 5.6%) were seen in no-show rates at the patient and program levels, respectively. Reductions were demonstrated for all program types, for most census regions, and for breast, gynecologic, and gastrointestinal cancers. The most frequently addressed barriers were transportation (62.3%) and patient illness unrelated to toxicity (37.1%). The most frequently implemented interventions included the development of a workflow and/or protocol related to identified barriers (68.9%) and the creation of internal resources to address these barriers (54.3%). CONCLUSIONS: Breaking Barriers is the largest prospective study to decrease rates of missed radiotherapy appointments across multiple program types, census regions, and disease sites. These findings demonstrate the strength of ACS-led National QI Collaborative as an effective large-scale approach to address modifiable barriers to high-quality cancer care delivery. 25:[[["$","script","0",{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"CollectionPage\",\"name\":\"Gynecologic Cancer: condition Research & Clinical Takeaways\",\"description\":\"Explore peer-reviewed papers on Gynecologic Cancer (condition). Clinician-written summaries and actionable practice insights. Updated daily.\",\"url\":\"https://www.reachrx.ai/hub/tag/condition/Gynecologic%20Cancer\",\"breadcrumb\":{\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://www.reachrx.ai\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research Hub\",\"item\":\"https://www.reachrx.ai/hub\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Conditions\",\"item\":\"https://www.reachrx.ai/hub/tag/condition\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Gynecologic Cancer\",\"item\":\"https://www.reachrx.ai/hub/tag/condition/Gynecologic%20Cancer\"}]}}"}}]],["$","$L2f",null,{"title":"Gynecologic Cancer: Research & Clinical Takeaways","description":"Discover peer-reviewed research on Gynecologic Cancer with concise clinician summaries and next-step guidance.","papers":[{"doi":"10.1016/j.ijgc.2026.104881","pmid":null,"title":"Hormone Replacement Therapy in Gynecologic Cancer Survivors: Bridging the Gap Between Evidence and Clinical Practice","journal_title":"International Journal of Gynecological Cancer","journal_issn":"1048-891X","published_at":"2026-08-03T00:00:00.000Z","url":"https://doi.org/10.1016/j.ijgc.2026.104881","source_score":1,"is_retracted":false,"is_open_access":false,"raw_metadata":{"pubmed":false,"crossref":true,"unpaywall":true},"created_at":"2026-08-11T13:26:10.399Z","updated_at":"2026-08-11T13:26:10.399Z","tags":[{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"category","value":"Obstetrics & Gynecology","value_numeric":null},{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"condition","value":"Gynecologic Cancer","value_numeric":null},{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"impact_flag","value":"limited_evidence","value_numeric":null},{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"level_of_evidence","value":"5","value_numeric":null},{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"modality","value":"Hormone Replacement Therapy","value_numeric":null},{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"sex","value":"female","value_numeric":null},{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"study_design","value":"Review","value_numeric":null},{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"warning","value":"No specific numerical outcomes, population size, or PICO details were available; key_result and sample_size tags were omitted accordingly.","value_numeric":null},{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"warning","value":"Study design tagged as 'Review' based on title framing ('Bridging the Gap Between Evidence and Clinical Practice'), but this is unconfirmed — it could be a commentary or narrative review.","value_numeric":null},{"paper_doi":"10.1016/j.ijgc.2026.104881","tag_type":"warning","value":"The paper abstract and full text were not provided — only the title and metadata were supplied. All structured outputs are inferred from the title and journal context alone. Key results, sample size, and specific study design could not be confirmed.","value_numeric":null}],"summaries":{"what_studied":"This paper evaluates the evidence base for hormone replacement therapy (HRT) use in gynecologic cancer survivors, examining the gap between available clinical evidence and real-world clinical practice.","limitations":"The paper appears to be a review or commentary rather than a primary trial, limiting the strength of any specific numerical outcomes; the evidence base for HRT in gynecologic cancer survivors is likely heterogeneous across cancer subtypes.","practice_takeaway":"Clinicians should be aware of the disconnect between existing evidence on HRT safety and its underuse in gynecologic cancer survivors; individualized shared decision-making is likely emphasized for this population."}},{"doi":"10.1002/cncr.70486","pmid":"42334857","title":"Fertility preservation access among female adolescents and young adults with cancer: A systematic review","journal_title":"Cancer","journal_issn":"0008-543X","published_at":"2026-06-23T00:00:00.000Z","url":"https://doi.org/10.1002/cncr.70486","source_score":35,"is_retracted":false,"is_open_access":true,"raw_metadata":{"pubmed":true,"crossref":true,"unpaywall":true},"created_at":"2026-06-27T13:27:36.387Z","updated_at":"2026-06-27T13:27:36.387Z","tags":[{"paper_doi":"10.1002/cncr.70486","tag_type":"age_group","value":"adolescent","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"category","value":"Oncology","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"condition","value":"Breast Cancer","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"condition","value":"Cancer","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"condition","value":"Gynecologic Cancer","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"condition","value":"Hematologic Malignancy","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"impact_flag","value":"safety_signal","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"level_of_evidence","value":"2","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"modality","value":"Embryo Cryopreservation","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"modality","value":"Fertility Preservation","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"modality","value":"Fertility-Sparing Surgery","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"modality","value":"GnRH Agonist","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"modality","value":"Oocyte Cryopreservation","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"modality","value":"Ovarian Tissue Cryopreservation","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"sample_size","value":"n=117790","value_numeric":117790},{"paper_doi":"10.1002/cncr.70486","tag_type":"sex","value":"female","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"study_design","value":"Systematic Review","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"warning","value":"Age inclusion criteria varied across the 25 included studies (upper limits ranging from 39 to 46 years), so some findings extend slightly beyond the strict AYA definition of 15–39 years.","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"warning","value":"Meta-analysis was not performed; all synthesis is narrative/descriptive, which limits quantitative precision of pooled estimates.","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"warning","value":"The PROSPERO registration number in the abstract (CRD420251077846) appears to contain an extra digit compared with standard PROSPERO format—this may be a typographical error in the source document.","value_numeric":null},{"paper_doi":"10.1002/cncr.70486","tag_type":"warning","value":"The 'safety_signal' impact flag is used here to highlight persistent, clinically meaningful disparities in FP access rather than a drug safety concern—the standard definition of safety signal may not apply.","value_numeric":null}],"summaries":{"what_studied":"This systematic review examined access to fertility preservation (FP) care among female AYAs (ages 15–39) with cancer in the US, synthesizing 25 observational studies published 2011–2025 (data spanning 1990–2021) covering 117,790 participants across 10 states plus 4 national datasets.","key_result":"FP discussion rates ranged from 9%–75%, fertility specialist consultation from 0.9%–57%, and FP procedure completion from 0.56%–70.3%. Key facilitators were younger age, private insurance, nulliparity, and higher SES. Key barriers were non-Hispanic Black or Hispanic race/ethnicity, public insurance, lower income, and rural residence. Institutional programs (e.g., oncofertility teams integrated into tumor boards) significantly raised consultation rates—from 0.9% to 23.3% in one study—but did not eliminate disparities.","limitations":"- Most studies were retrospective with secondary data (registries, claims, chart review), prone to underreporting and incomplete confounder adjustment.\n- Samples were predominantly non-Hispanic White and privately insured, limiting generalizability to underserved populations.\n- Few studies included longitudinal follow-up, so whether early FP access improves reproductive or psychosocial outcomes remains unknown.","practice_takeaway":"Oncologists should offer routine, standardized FP counseling to all female AYAs at diagnosis—not just younger or privately insured patients—because disparities persist across race, income, and geography. Integrating fertility specialists into multidisciplinary tumor boards and using patient navigation are evidence-supported strategies to improve equitable access."}},{"doi":"10.1007/s00192-026-06682-9","pmid":"42115340","title":"Effectiveness of Pelvic Floor Physiotherapy Techniques in Women with Sequels of Gynecologic Cancer: A Systematic Review","journal_title":"International Urogynecology Journal","journal_issn":"0937-3462","published_at":"2026-05-11T00:00:00.000Z","url":"https://doi.org/10.1007/s00192-026-06682-9","source_score":2,"is_retracted":false,"is_open_access":false,"raw_metadata":{"pubmed":true,"crossref":true,"unpaywall":true},"created_at":"2026-05-17T13:21:31.166Z","updated_at":"2026-05-17T13:21:31.166Z","tags":[{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"category","value":"Obstetrics & Gynecology","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"condition","value":"Gynecologic Cancer","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"condition","value":"Pelvic Floor Dysfunction","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"condition","value":"Sexual Dysfunction","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"condition","value":"Urinary Incontinence","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"impact_flag","value":"confirms_prior","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"level_of_evidence","value":"2","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"modality","value":"Dilator Therapy","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"modality","value":"Pelvic Floor Muscle Training","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"modality","value":"Pelvic Floor Physiotherapy","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"sample_size","value":"n=10","value_numeric":10},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"sex","value":"female","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"study_design","value":"Systematic Review","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"warning","value":"Individual study sample sizes, effect sizes, and statistical outcomes are not available from the provided text; numeric findings cannot be verified or reported.","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"warning","value":"The full text provided is a CASPe critical appraisal checklist document in Spanish — it does not contain the actual systematic review body, study tables, or quantitative results. All extracted data is based solely on the abstract and results sections supplied.","value_numeric":null},{"paper_doi":"10.1007/s00192-026-06682-9","tag_type":"warning","value":"The 'n=10 studies' sample size tag reflects included studies, not individual participants — total participant count is not reported in the available text.","value_numeric":null}],"summaries":{"what_studied":"This systematic review evaluated the effectiveness of pelvic floor physiotherapy techniques (muscle training, dilator therapy, sexual education) for managing sequelae of gynecological cancer in women, drawing on 10 studies from 82 identified across PubMed, PEDro, Cochrane Library, and ScienceDirect (past 10 years).","key_result":"Pelvic floor muscle training (alone or combined) improved sexual function, urinary incontinence, muscle strength, and health-related quality of life. Dilator therapy (alone or with sexual education) reduced sexual dysfunction complications and psychosexual symptoms.","limitations":"Only 10 of 82 identified articles met inclusion criteria, limiting the evidence base. The full text provided does not contain study-level data, so individual effect sizes and sample sizes cannot be verified. Methodological heterogeneity across included studies (assessed via PEDro, CASPe, ROBINS-1, and RoB2) may limit pooled conclusions.","practice_takeaway":"Consider referring women with gynecological cancer sequelae to pelvic floor physiotherapy — muscle training and dilator therapy have evidence supporting improvements in urinary incontinence, sexual function, and quality of life. Combining dilator therapy with sexual education may add benefit for psychosexual symptoms."}},{"doi":"10.1016/j.ygyno.2026.01.135","pmid":null,"title":"Growth is good: Medicaid expansion positively impacts palliative care and survival in gynecologic cancers","journal_title":"Gynecologic Oncology","journal_issn":"0090-8258","published_at":"2026-04-23T00:00:00.000Z","url":"https://doi.org/10.1016/j.ygyno.2026.01.135","source_score":7,"is_retracted":false,"is_open_access":false,"raw_metadata":{"pubmed":false,"crossref":true,"unpaywall":true},"created_at":"2026-05-07T22:50:06.216Z","updated_at":"2026-05-07T22:50:06.216Z","tags":[{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"category","value":"Obstetrics & Gynecology","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"condition","value":"Gynecologic Cancer","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"impact_flag","value":"practice_changing","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"level_of_evidence","value":"3","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"modality","value":"Palliative Care","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"sex","value":"female","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"study_design","value":"Observational Study","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"warning","value":"Impact flag 'practice_changing' reflects the policy relevance implied by the title but is uncertain without full results.","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"warning","value":"Level of evidence is estimated based on assumed study design; actual LOE may differ.","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"warning","value":"No sample size could be extracted — the sample_size tag was omitted due to lack of data.","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"warning","value":"Only the paper title and metadata were provided — no abstract, methods, results, or sample size were available. All summary content is inferred from the title alone and should be interpreted with caution.","value_numeric":null},{"paper_doi":"10.1016/j.ygyno.2026.01.135","tag_type":"warning","value":"Study design is assumed to be observational/retrospective (common for Medicaid expansion policy studies); this could not be confirmed from the provided text.","value_numeric":null}],"summaries":{"what_studied":"This study evaluated the impact of Medicaid expansion (under the Affordable Care Act) on access to palliative care and survival outcomes in patients with gynecologic cancers.","key_result":"Medicaid expansion was associated with positive improvements in both palliative care utilization and survival outcomes among gynecologic cancer patients, though specific absolute numbers were not available in the provided abstract.","limitations":"The study design (likely retrospective/observational using administrative or registry data) limits causal inference; residual confounding from unmeasured socioeconomic variables is possible; findings may not generalize across all states or healthcare systems.","practice_takeaway":"Medicaid expansion appears to benefit gynecologic cancer patients by improving access to palliative care and survival. Clinicians and policymakers should consider insurance coverage expansion as a meaningful lever for improving cancer outcomes in underserved populations."}},{"doi":"10.1097/xcs.0000000000001637","pmid":"41217348","title":"Results of an American College of Surgeons Prospective National Quality Improvement Collaborative to Successfully Overcome Barriers to Cancer Care Across the US","journal_title":"Journal of the American College of Surgeons","journal_issn":"1072-7515","published_at":"2025-11-11T00:00:00.000Z","url":"https://doi.org/10.1097/xcs.0000000000001637","source_score":246,"is_retracted":false,"is_open_access":false,"raw_metadata":{"ooir":{"day":"2025-12-23","doi":"10.1097/xcs.0000000000001637","days":"30","issn":"1072-7515","rank":"2","field":"Clinical Medicine","score":"246","category":"Surgery","categories":["Surgery"],"_categories":["Surgery"]},"pubmed":{"doi":"10.1097/XCS.0000000000001637","title":"Results of an American College of Surgeons Prospective National Quality Improvement Collaborative to Successfully Overcome Barriers to Cancer Care Across the US.","journal":"Journal of the American College of Surgeons","methods":"","results":"Reductions of 39.8% (from 8.3% to 5.0%) and 31.7% (from 8.2% to 5.6%) were seen in no-show rates at the patient and program levels, respectively. Reductions were demonstrated for all program types, for most census regions, and for breast, gynecologic, and gastrointestinal cancers. The most frequently addressed barriers were transportation (62.3%) and patient illness unrelated to toxicity (37.1%). The most frequently implemented interventions included the development of a workflow and/or protocol related to identified barriers (68.9%) and the creation of internal resources to address these barriers (54.3%).","abstract":"$30","keywords":[],"pubmed_id":"41217348","conclusions":"","publication_date":"2025-11-11T00:00:00"},"crossref":{"DOI":"10.1097/xcs.0000000000001637","URL":"https://doi.org/10.1097/xcs.0000000000001637","ISSN":["1072-7515","1879-1190"],"link":[{"URL":"https://journals.lww.com/10.1097/XCS.0000000000001637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":"247-256","type":"journal-article","issue":"1","score":1,"title":["Results of an American College of Surgeons Prospective National Quality Improvement Collaborative to Successfully Overcome Barriers to Cancer Care Across the US"],"author":[{"given":"Kelley","family":"Chan","sequence":"first","affiliation":[{"name":"From the American College of Surgeons Cancer Programs, Chicago, IL (Chan, Reilly, Weigel, Kirstein)"},{"name":"Department of Surgery, Loyola University Chicago Stritch School of Medicine, Maywood, IL (Chan)"}]},{"given":"Eileen","family":"Reilly","sequence":"additional","affiliation":[{"name":"From the American College of Surgeons Cancer Programs, Chicago, IL (Chan, Reilly, Weigel, Kirstein)"}]},{"given":"Lauren M","family":"Janczewski","sequence":"additional","affiliation":[{"name":"Department of Surgery, Feinberg School of Medicine Northwestern University, Chicago, IL (Janczewski)"}]},{"given":"Sharon","family":"Gentry","sequence":"additional","affiliation":[{"name":"Academy of Oncology Nurse and Patient Navigators, Cranbury, NJ (Gentry)"}]},{"given":"Camille","family":"Biggins","sequence":"additional","affiliation":[{"name":"Virginia Mason Franciscan Health, Seattle, WA (Biggins)"}]},{"given":"Bruce","family":"Haffty","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (Haffty)"}]},{"given":"Charles","family":"Shelton","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Outer Banks Health, Nags Head, NC (Shelton)"}]},{"given":"Anthony D","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Indiana University School of Medicine, Indianapolis, IN (Yang)"}]},{"given":"Ronald J","family":"Weigel","sequence":"additional","affiliation":[{"name":"From the American College of Surgeons Cancer Programs, Chicago, IL (Chan, Reilly, Weigel, Kirstein)"},{"name":"Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA (Weigel)"}]},{"given":"Laurie J","family":"Kirstein","sequence":"additional","affiliation":[{"name":"From the American College of Surgeons Cancer Programs, Chicago, IL (Chan, Reilly, Weigel, Kirstein)"},{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY (Kirstein)."}]}],"issued":{"date-parts":[[2025,12,17]]},"member":"276","prefix":"10.1097","source":"Crossref","volume":"242","created":{"date-time":"2025-11-11T16:01:57Z","timestamp":1762876917000,"date-parts":[[2025,11,11]]},"indexed":{"date-time":"2025-12-18T08:06:48Z","timestamp":1766045208777,"date-parts":[[2025,12,18]]},"subject":[],"abstract":"$31","language":"en","relation":{},"resource":{"primary":{"URL":"https://journals.lww.com/10.1097/XCS.0000000000001637"}},"subtitle":[],"deposited":{"date-time":"2025-12-18T08:03:26Z","timestamp":1766045006000,"date-parts":[[2025,12,18]]},"issn-type":[{"type":"print","value":"1072-7515"},{"type":"electronic","value":"1879-1190"}],"published":{"date-parts":[[2025,12,17]]},"publisher":"Ovid Technologies (Wolters Kluwer Health)","reference":[{"DOI":null,"key":"R1-20251218","year":"2025","issue":null,"author":"Siegel","volume":"75","first-page":"10","unstructured":null,"article-title":"Cancer statistics, 2025.","journal-title":"CA Cancer J Clin","doi-asserted-by":null},{"DOI":"10.1002/cncr.22916","key":"R2-20251218","year":"2007","issue":null,"author":"Bilimoria","volume":"110","first-page":"1227","unstructured":null,"article-title":"Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume.","journal-title":"Cancer","doi-asserted-by":"crossref"},{"DOI":"10.1245/s10434-015-4677-y","key":"R3-20251218","year":"2015","issue":null,"author":"Lowenfeld","volume":"22","first-page":"S863","unstructured":null,"article-title":"Multimodality treatment of T4 gastric cancer in the United States: utilization trends and impact on survival.","journal-title":"Ann Surg Oncol","doi-asserted-by":"crossref"},{"DOI":"10.6004/jnccn.2021.0012","key":"R4-20251218","year":"2021","issue":null,"author":"Benson","volume":"19","first-page":"329","unstructured":null,"article-title":"Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology.","journal-title":"J Natl Compr Canc Netw","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.ijrobp.2016.01.043","key":"R5-20251218","year":"2016","issue":null,"author":"Ohri","volume":"95","first-page":"563","unstructured":null,"article-title":"Radiation therapy noncompliance and clinical outcomes in an urban academic cancer center.","journal-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.ijrobp.2014.09.030","key":"R6-20251218","year":"2015","issue":null,"author":"Ohri","volume":"91","first-page":"232","unstructured":null,"article-title":"Predictors of radiation therapy noncompliance in an urban academic cancer center.","journal-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"crossref"},{"DOI":"10.1097/COC.0000000000000293","key":"R7-20251218","year":"2018","issue":null,"author":"Deek","volume":"41","first-page":"362","unstructured":null,"article-title":"Prognostic impact of missed chemotherapy doses during chemoradiation therapy for non-small cell lung cancer.","journal-title":"Am J Clin Oncol","doi-asserted-by":"crossref"},{"DOI":"10.1245/s10434-024-15393-8","key":"R8-20251218","year":"2024","issue":null,"author":"Palis","volume":"31","first-page":"5546","unstructured":null,"article-title":"The national cancer database conforms to the standardized framework for registry and data quality.","journal-title":"Ann Surg Oncol","doi-asserted-by":"crossref"},{"DOI":"10.1200/OP-24-00745","key":"R13-20251218","year":"2025","issue":null,"author":"Janczewski","volume":"21","first-page":"1185","unstructured":null,"article-title":"If we build it, why they do not come? An American College of Surgeons national quality improvement collaborative to understand barriers to completion of cancer treatment.","journal-title":"JCO Oncol Pract","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jbi.2008.08.010","key":"R15-20251218","year":"2009","issue":null,"author":"Harris","volume":"42","first-page":"377","unstructured":null,"article-title":"Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support.","journal-title":"J Biomed Inform","doi-asserted-by":"crossref"},{"DOI":"10.1002/jso.24690","key":"R16-20251218","year":"2017","issue":null,"author":"Matsuo","volume":"116","first-page":"482","unstructured":null,"article-title":"Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer.","journal-title":"J Surg Oncol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jmir.2010.08.002","key":"R17-20251218","year":"2010","issue":null,"author":"Giddings","volume":"41","first-page":"222","unstructured":null,"article-title":"Treatment interruptions in radiation therapy for head-and-neck cancer: rates and causes.","journal-title":"J Med Imaging Radiat Sci","doi-asserted-by":"crossref"},{"DOI":"10.1200/JCO.23.00993","key":"R18-20251218","year":"2024","issue":null,"author":"Biddell","volume":"42","first-page":"300","unstructured":null,"article-title":"Economic evaluation of a nonmedical financial assistance program on missed treatment appointments among adults with cancer.","journal-title":"J Clin Oncol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.ijrobp.2021.10.144","key":"R19-20251218","year":"2022","issue":null,"author":"Maroongroge","volume":"112","first-page":"600","unstructured":null,"article-title":"Geographic access to radiation therapy facilities in the United States.","journal-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.adro.2021.100802","key":"R20-20251218","year":"2021","issue":null,"author":"Mattes","volume":"6","first-page":"100802","unstructured":null,"article-title":"Overcoming barriers to radiation oncology access in low-resource settings in the United States.","journal-title":"Adv Radiat Oncol","doi-asserted-by":"crossref"},{"DOI":"10.1097/MLR.0000000000000458","key":"R21-20251218","year":"2016","issue":null,"author":"McAlearney","volume":"54","first-page":"147","unstructured":null,"article-title":"The challenge of improving breast cancer care coordination in safety-net hospitals: barriers, facilitators, and opportunities.","journal-title":"Med Care","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.ijrobp.2022.06.075","key":"R22-20251218","year":"2023","issue":null,"author":"Morris","volume":"116","first-page":"28","unstructured":null,"article-title":"Sociodemographic and clinical factors associated with radiation treatment nonadherence and survival among rural and nonrural patients with cancer.","journal-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"crossref"},{"DOI":"10.1245/s10434-020-08867-y","key":"R23-20251218","year":"2021","issue":null,"author":"Tucker","volume":"28","first-page":"632","unstructured":null,"article-title":"Improving the quality of cancer care in community hospitals.","journal-title":"Ann Surg Oncol","doi-asserted-by":"crossref"},{"DOI":"10.1080/13557858.2015.1034658","key":"R24-20251218","year":"2016","issue":null,"author":"Costas-Muniz","volume":"21","first-page":"118","unstructured":null,"article-title":"Association of socioeconomic and practical unmet needs with self-reported nonadherence to cancer treatment appointments in low-income Latino and Black cancer patients.","journal-title":"Ethn Health","doi-asserted-by":"crossref"},{"DOI":"10.3389/fonc.2016.00002","key":"R25-20251218","year":"2016","issue":null,"author":"Krok-Schoen","volume":"6","first-page":"2","unstructured":null,"article-title":"Cancer care delivery and women’s health: the role of patient navigation.","journal-title":"Front Oncol","doi-asserted-by":"crossref"},{"DOI":"10.1002/cncr.27487","key":"R26-20251218","year":"2012","issue":null,"author":"Donaldson","volume":"118","first-page":"4851","unstructured":null,"article-title":"Patient navigation for breast and colorectal cancer in 3 community hospital settings: an economic evaluation.","journal-title":"Cancer","doi-asserted-by":"crossref"},{"DOI":"10.1177/1062860616656250","key":"R27-20251218","year":"2017","issue":null,"author":"Castaldi","volume":"32","first-page":"406","unstructured":null,"article-title":"A multidisciplinary patient navigation program improves compliance with adjuvant breast cancer therapy in a public hospital.","journal-title":"Am J Med Quality","doi-asserted-by":"crossref"},{"DOI":null,"key":"R28-20251218","year":"2023","issue":null,"author":"Vieira","volume":"31","first-page":"182","unstructured":null,"article-title":"Patient navigation (PN) support to timely access to radiotherapy in the Brazilian public health system.","journal-title":"Support Care Cancer","doi-asserted-by":null},{"DOI":"10.1177/1078155220950003","key":"R29-20251218","year":"2021","issue":null,"author":"Monestime","volume":"27","first-page":"1094","unstructured":null,"article-title":"Factors associated with adherence to follow-up calls in cancer patients receiving care at a community oncology practice.","journal-title":"J Oncol Pharm Pract","doi-asserted-by":"crossref"},{"DOI":"10.7812/TPP/23.046","key":"R30-20251218","year":"2023","issue":null,"author":"Katzel","volume":"27","first-page":"60","unstructured":null,"article-title":"Real-world use of electronic patient-reported outcome (ePRO) tools integrated in the electronic medical record during radiation therapy for head and neck cancer: feasibility study.","journal-title":"Perm J","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.ijrobp.2018.11.050","key":"R31-20251218","year":"2019","issue":null,"author":"Tan","volume":"103","first-page":"1045","unstructured":null,"article-title":"Automated text message reminders improve radiation therapy compliance.","journal-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"crossref"},{"DOI":"10.1186/s13012-018-0726-9","key":"R32-20251218","year":"2018","issue":null,"author":"Geerligs","volume":"13","first-page":"36","unstructured":null,"article-title":"Hospital-based interventions: a systematic review of staff-reported barriers and facilitators to implementation processes.","journal-title":"Implement Sci","doi-asserted-by":"crossref"},{"DOI":"10.1001/jamasurg.2020.2842","key":"R34-20251218","year":"2020","issue":null,"author":"Yuce","volume":"155","first-page":"934","unstructured":null,"article-title":"Association between implementing comprehensive learning collaborative strategies in a statewide collaborative and changes in hospital safety culture.","journal-title":"JAMA Surg","doi-asserted-by":"crossref"},{"DOI":"10.1530/EJE-10-1038","key":"R35-20251218","year":"2011","issue":null,"author":"Asscheman","volume":"164","first-page":"635","unstructured":null,"article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.","journal-title":"Eur J Endocrinol","doi-asserted-by":"crossref"}],"short-title":[],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"update-policy":"https://doi.org/10.1097/lww.0000000000001000","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"original-title":[],"container-title":["Journal of the American College of Surgeons"],"published-print":{"date-parts":[[2026,1]]},"reference-count":29,"published-online":{"date-time":null,"timestamp":null,"date-parts":[[2025,12,17]]},"references-count":29,"short-container-title":[],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1097/xcs.0000000000001637","is_oa":false,"title":"Results of an American College of Surgeons Prospective National Quality Improvement Collaborative to Successfully Overcome Barriers to Cancer Care Across the US","updated":"2025-11-13T08:10:39+00:00","published_date":"2025-11-11","best_oa_location":null}},"created_at":"2025-12-05T07:03:31.304Z","updated_at":"2026-01-20T15:55:50.695Z","tags":[{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"category","value":"Surgery","value_numeric":null},{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"condition","value":"Breast Cancer","value_numeric":null},{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"condition","value":"Cancer","value_numeric":null},{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"condition","value":"Gastrointestinal Cancer","value_numeric":null},{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"condition","value":"Gynecologic Cancer","value_numeric":null},{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"modality","value":"Radiotherapy","value_numeric":null},{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"sample_size","value":"n=99,057","value_numeric":99057},{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"study_design","value":"Before-After Study","value_numeric":null},{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"warning","value":"Design appears to be a national prospective QI before–after initiative; randomization was not reported.","value_numeric":null},{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"warning","value":"Only abstract-level methods are provided; details on timing and statistical approach beyond chi-squared tests are limited.","value_numeric":null},{"paper_doi":"10.1097/xcs.0000000000001637","tag_type":"warning","value":"The abstract mentions both “no-shows” and identifying patients with ≥3 missed treatments; definitions and thresholds are not fully detailed.","value_numeric":null}],"summaries":{"what_studied":"A two-year prospective national quality improvement collaborative across 194 ACS-accredited cancer programs (March 2023–December 2024) to cut missed radiotherapy appointments by 20% among 99,057 scheduled patients, using needs assessments, education, peer learning, and an ACS toolkit.","key_result":"Patient-level no-shows fell 39.8% from 8.3% to 5.0%, and program-level rates fell 31.7% from 8.2% to 5.6%. Transportation (62.3%) and patient illness unrelated to toxicity (37.1%) were the most addressed barriers; common interventions were new workflows/protocols (68.9%) and creation of internal resources (54.3%).","practice_takeaway":"An ACS-led, structured QI approach with standardized workflows and resources was associated with large drops in missed radiotherapy visits across program types and regions, including breast, gynecologic, and GI cancers. Targeting transportation and non-toxicity illness barriers were frequent and feasible actions."}}],"initialOffset":5,"fetchConfig":{"kind":"tags","tags":[{"tag_type":"condition","value":"Gynecologic Cancer"}]},"breadcrumbItems":[{"name":"Home","href":"/"},{"name":"Research Hub","href":"/hub"},{"name":"Conditions","href":"/hub/tag/condition"},{"name":"Gynecologic Cancer"}],"hrefConfig":{"basePath":"/hub/papers","webViewQueryParams":{"hub_ctx":"tag","hub_tag_type":"condition","hub_tag_value":"Gynecologic Cancer"}}}]]

Papers